Boyd Watterson Asset Management LLC OH bought a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the first quarter, Holdings Channel.com reports. The institutional investor bought 7,736 shares of the financial services provider’s stock, valued at approximately $1,342,000.
Several other institutional investors have also made changes to their positions in MRSH. Numerai GP LLC grew its stake in shares of Marsh & McLennan Companies by 966.2% in the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock valued at $7,501,000 after purchasing an additional 33,729 shares during the period. Swiss Life Asset Management Ltd raised its holdings in shares of Marsh & McLennan Companies by 9.5% in the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock valued at $24,960,000 after buying an additional 11,648 shares during the last quarter. Barclays PLC grew its stake in shares of Marsh & McLennan Companies by 41.7% during the third quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock valued at $443,844,000 after purchasing an additional 647,987 shares during the last quarter. Sarasin & Partners LLP increased its stake in shares of Marsh & McLennan Companies by 0.9% in the 4th quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock valued at $173,411,000 after buying an additional 8,283 shares during the period. Finally, CSM Advisors LLC acquired a new stake in Marsh & McLennan Companies in the third quarter worth about $1,180,000. 87.99% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Marsh & McLennan Companies
In other news, CEO John Q. Doyle sold 16,656 shares of the firm’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the sale, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $18,889,506.81. This trade represents a 12.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.38% of the company’s stock.
Marsh & McLennan Companies Stock Performance
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last posted its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, topping the consensus estimate of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The business had revenue of $7.30 billion during the quarter. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. As a group, analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several analysts have commented on MRSH shares. JPMorgan Chase & Co. dropped their target price on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating for the company in a research report on Thursday, April 9th. Weiss Ratings downgraded shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Mizuho cut their target price on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating on the stock in a research note on Monday, April 13th. Bank of America lowered their target price on Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating on the stock in a research report on Tuesday, April 14th. Finally, Morgan Stanley cut their price target on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a research note on Monday, April 6th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Marsh & McLennan Companies has a consensus rating of “Hold” and a consensus price target of $200.19.
Check Out Our Latest Report on MRSH
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Read More
- Five stocks we like better than Marsh & McLennan Companies
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
